共 19 条
- [1] Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2019, 10
- [2] Development and Seroconversion of Anti-Cytolethal Distending Toxin(CdtB) and Anti-Vinculin Antibodies in a Patient with Evolving Post-infectious IBS [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S807 - S807
- [3] Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome [J]. Digestive Diseases and Sciences, 2017, 62 : 1480 - 1485
- [7] Cytolethal distending toxin: from genotoxin to a potential biomarker and anti-tumor target [J]. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, 2021, 37 (09):
- [8] Cytolethal distending toxin: from genotoxin to a potential biomarker and anti-tumor target [J]. World Journal of Microbiology and Biotechnology, 2021, 37
- [10] ESTIMATING DIAGNOSTIC COSTS ASSOCIATED WITH A SECOND-GENERATION BLOOD TEST FOR ANTI-VINCULIN AND ANTI-CYTOLETHAL DISTENDING TOXIN B (CDTB) BIOMARKERS IN COMPARISON TO THE STANDARD EXCLUSIONARY APPROACH FOR IRRITABLE BOWEL SYNDROME WITH A DIARRHEAL COMPONENT (IBS-D/M) [J]. VALUE IN HEALTH, 2020, 23 : S146 - S146